跳至主要内容
临床试验/NL-OMON55649
NL-OMON55649已完成不适用

INDICO AF - Atrial Fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease. - INDICO AF

Academisch Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age between 18 and 80 years
  • CAD, evident from a) previous myocardial infarction or b) revascularization
  • through PCI or CABG
  • LVEF<35%, quantified on MRI, with nuclear imaging or determined by
  • echocardiography
  • Willing and able to sign informed consent and to comply with the protocol and
  • with the follow-up
  • Life expectancy > 2 years

排除标准

  • Unwilling to sign informed consent
  • Current atrial fibrillation
  • A history of atrial fibrillation not including postoperative atrial
  • fibrillation
  • Previous catheter or surgical ablation for atrial fibrillation
  • Current use or current indication of vitamin K antagonist or NOACs
  • Use of class 1 or 3 antiarrhythmic drugs for ventricular or supraventricular
  • arrhythmia ` other than AF
  • Prosthetic heart valves
  • Dilated or hypertrophic cardiomyopathy
  • Congenital heart disease for which surgical correction was performed
  • Inherited arrhythmia syndrome
  • Active malignant disease
  • Use of antracyclins in the history
  • Being pregnant or of child bearing potential
  • Life expectancy<2 years

研究者

相似试验